Caremax Inc (CMAX)

$2.4

-0.11

(-4.38%)▲

Market is closed - opens 7 PM, 19 Apr 2024

Insights on Caremax Inc

  • Decreasing Revenue

    Revenue is down for the last 3 quarters, 224.44M → 151.83M (in $), with an average decrease of 17.4% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, -32.37M → -465.76M (in $), with an average decrease of 285.1% per quarter

  • Vs HQY

    In the last 1 year, Healthequity Inc has given 37.0% return, outperforming this stock by 133.7%

  • Vs HQY

    In the last 3 years, Healthequity Inc has given 12.5% return, outperforming this stock by 93.5%

Performance

  • $2.24
    $2.70
    $2.40
    downward going graph

    6.88%

    Downside

    Day's Volatility :17.28%

    Upside

    11.18%

    downward going graph
  • $2.40
    $126.00
    $2.40
    downward going graph

    0.0%

    Downside

    52 Weeks Volatility :98.1%

    Upside

    98.1%

    downward going graph

Returns

PeriodCaremax IncSector (Health Care)Index (Russel 2000)
3 Months
-73.35%
-0.7%
0.0%
6 Months
-96.28%
6.6%
0.0%
1 Year
-96.72%
3.7%
-1.5%
3 Years
-80.74%
14.0%
-21.8%

Highlights

Market Capitalization
11.1M
Book Value
$16.41
Earnings Per Share (EPS)
-183.29
Wall Street Target Price
33.6
Profit Margin
-90.98%
Operating Margin TTM
-55.2%
Return On Assets TTM
-7.58%
Return On Equity TTM
-200.69%
Revenue TTM
751.1M
Revenue Per Share TTM
201.49
Quarterly Revenue Growth YOY
-7.6%
Gross Profit TTM
80.3M
EBITDA
-81.1M
Diluted Eps TTM
-183.29
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-13.9
EPS Estimate Next Year
-3.73
EPS Estimate Current Quarter
-4.73
EPS Estimate Next Quarter
-5.06

Analyst Recommendation

Buy
    75%Buy
    25%Hold
    0
    0%Sell
Based on 12 Wall street analysts offering stock ratings for Caremax Inc(by analysts ranked 0 to 5 stars)
Based on 12 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
9
9
9
Hold
3
3
3
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 1300.0%

Current $2.40
Target $33.60

Company Financials

FY19Y/Y Change
Revenue
90.6M
-
Net Income
6.0M
-
Net Profit Margin
6.64%
-
FY20Y/Y Change
Revenue
103.4M
↑ 14.15%
Net Income
5.9M
↓ 1.27%
Net Profit Margin
5.75%
↓ 0.89%
FY21Y/Y Change
Revenue
295.8M
↑ 185.98%
Net Income
-6.7M
↓ 212.35%
Net Profit Margin
-2.26%
↓ 8.01%
FY22Y/Y Change
Revenue
631.1M
↑ 113.39%
Net Income
-37.8M
↑ 466.16%
Net Profit Margin
-5.99%
↓ 3.73%
FY23Y/Y Change
Revenue
751.1M
↑ 19.01%
Net Income
-683.3M
↑ 1707.94%
Net Profit Margin
-90.98%
↓ 84.99%
Q3 FY22Q/Q Change
Revenue
157.7M
↓ 8.48%
Net Income
-22.1M
↑ 135.11%
Net Profit Margin
-13.99%
↓ 8.55%
Q4 FY22Q/Q Change
Revenue
164.3M
↑ 4.18%
Net Income
10.4M
↓ 147.31%
Net Profit Margin
6.35%
↑ 20.34%
Q1 FY23Q/Q Change
Revenue
173.0M
↑ 5.31%
Net Income
-82.1M
↓ 886.67%
Net Profit Margin
-47.45%
↓ 53.8%
Q2 FY23Q/Q Change
Revenue
224.4M
↑ 29.75%
Net Income
-32.4M
↓ 60.56%
Net Profit Margin
-14.43%
↑ 33.02%
Q3 FY23Q/Q Change
Revenue
201.8M
↓ 10.07%
Net Income
-103.1M
↑ 218.52%
Net Profit Margin
-51.09%
↓ 36.66%
Q4 FY23Q/Q Change
Revenue
151.8M
↓ 24.78%
Net Income
-465.8M
↑ 351.66%
Net Profit Margin
-306.76%
↓ 255.67%
FY19Y/Y Change
Total Assets
24.3M
-
Total Liabilities
19.4M
-
FY20Y/Y Change
Total Assets
38.5M
↑ 58.25%
Total Liabilities
31.8M
↑ 63.92%
FY21Y/Y Change
Total Assets
653.1M
↑ 1596.21%
Total Liabilities
147.7M
↑ 364.89%
FY22Y/Y Change
Total Assets
1.2B
↑ 79.26%
Total Liabilities
551.2M
↑ 273.13%
FY23Y/Y Change
Total Assets
623.3M
↓ 46.76%
Total Liabilities
561.9M
↑ 1.93%
Q3 FY22Q/Q Change
Total Assets
707.4M
↓ 0.22%
Total Liabilities
238.2M
↑ 7.87%
Q4 FY22Q/Q Change
Total Assets
1.2B
↑ 65.49%
Total Liabilities
551.2M
↑ 131.37%
Q1 FY23Q/Q Change
Total Assets
1.1B
↓ 6.24%
Total Liabilities
557.9M
↑ 1.22%
Q2 FY23Q/Q Change
Total Assets
1.2B
↑ 4.85%
Total Liabilities
526.5M
↓ 5.64%
Q3 FY23Q/Q Change
Total Assets
1.1B
↓ 8.07%
Total Liabilities
533.5M
↑ 1.34%
Q4 FY23Q/Q Change
Total Assets
623.3M
↓ 41.09%
Total Liabilities
561.9M
↑ 5.32%
FY18Y/Y Change
Operating Cash Flow
584.8K
-
Investing Cash Flow
-934.6K
-
Financing Cash Flow
342.2K
-
FY19Y/Y Change
Operating Cash Flow
7.0M
↑ 1099.68%
Investing Cash Flow
-11.2M
↑ 1101.17%
Financing Cash Flow
8.4M
↑ 2344.98%
FY20Y/Y Change
Operating Cash Flow
5.3M
↓ 24.22%
Investing Cash Flow
-6.6M
↓ 41.1%
Financing Cash Flow
2.1M
↓ 74.63%
FY21Y/Y Change
Operating Cash Flow
-23.9M
↓ 548.76%
Investing Cash Flow
-316.6M
↑ 4687.19%
Financing Cash Flow
383.4M
↑ 17960.2%
FY22Y/Y Change
Operating Cash Flow
-68.2M
↑ 185.95%
Investing Cash Flow
-62.5M
↓ 80.26%
Financing Cash Flow
124.4M
↓ 67.55%
Q3 FY22Q/Q Change
Operating Cash Flow
-12.4M
↓ 18.65%
Investing Cash Flow
-2.1M
↑ 45.58%
Financing Cash Flow
-326.0K
↓ 100.63%
Q4 FY22Q/Q Change
Operating Cash Flow
-28.4M
↑ 128.83%
Investing Cash Flow
-57.5M
↑ 2671.34%
Financing Cash Flow
74.2M
↓ 22875.77%
Q1 FY23Q/Q Change
Operating Cash Flow
-21.7M
↓ 23.44%
Investing Cash Flow
-2.3M
↓ 96.03%
Financing Cash Flow
26.6M
↓ 64.14%
Q2 FY23Q/Q Change
Operating Cash Flow
-21.5M
↓ 1.05%
Investing Cash Flow
-2.9M
↑ 28.96%
Financing Cash Flow
34.9M
↑ 30.88%

Technicals Summary

Sell

Neutral

Buy

Caremax Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Caremax Inc
Caremax Inc
-40.8%
-96.28%
-96.72%
-80.74%
-74.65%
Solventum Corp
Solventum Corp
-10.64%
-10.64%
-10.64%
-10.64%
-10.64%
Veeva Systems Inc.
Veeva Systems Inc.
-12.8%
-3.39%
8.83%
-26.33%
55.83%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
-5.98%
30.6%
1.83%
40.83%
40.83%
Healthequity Inc
Healthequity Inc
-3.72%
6.22%
37.05%
12.91%
23.47%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Caremax Inc
Caremax Inc
NA
NA
NA
-13.9
-2.01
-0.08
NA
16.41
Solventum Corp
Solventum Corp
NA
NA
NA
0.0
0.12
0.08
NA
NA
Veeva Systems Inc.
Veeva Systems Inc.
62.03
62.03
1.35
4.76
0.13
0.05
NA
28.8
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
28.08
28.08
20.11
4.3
0.19
0.06
0.0
15.67
Healthequity Inc
Healthequity Inc
125.42
125.42
2.29
2.19
0.03
0.03
NA
23.63
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Caremax Inc
Caremax Inc
Buy
$11.1M
-74.65%
NA
-90.98%
Solventum Corp
Solventum Corp
NA
$11.7B
-10.64%
NA
16.42%
Veeva Systems Inc.
Veeva Systems Inc.
Buy
$32.3B
55.83%
62.03
22.24%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
Buy
$39.0B
40.83%
28.08
8.02%
Healthequity Inc
Healthequity Inc
Buy
$6.9B
23.47%
125.42
5.57%

Institutional Holdings

  • Deerfield Management Co

    14.13%

  • Morgan Stanley - Brokerage Accounts

    9.42%

  • Eminence Capital LLC

    8.80%

  • Maverick Capital Ltd

    4.51%

  • BlackRock Inc

    4.19%

  • Vanguard Group Inc

    3.87%

Corporate Announcements

  • Caremax Inc Earnings

    Caremax Inc’s price-to-earnings ratio stands at None

    Read More

Company Information

Organization
Caremax Inc
Employees
1450
CEO
Mr. Carlos A. de Solo
Industry
Healthcare

Discover More

FAQs